BioSpace News Archive

Biotech Bay

Clinical Trial Results of the BCMA CAR-T Co-developed by IASO Biotherapeutics and Innovent Commented in American Society of Hematology’s Medical Journal, Blood

IASO Biotherapeutics (IASO Bio) and Innovent Biologics, Inc. (Innovent, HKEX: 01801) today announced that the results of initial clinical studies on treatment of relapsed or refractory multiple myeloma (RRMM) in subjects using fully human BCMA-targeting CAR (CT103A).

June 3, 2021
·
13 min read
Drug Development

Antengene Announces Publication of Abstract on XPO1 Inhibitor Selinexor in Relapsed or Refractory Multiple Myeloma at ASCO 2021 and EHA 2021

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), announced that the results from the Phase II MARCH trial of selinexor plus low dose dexamethasone.

June 3, 2021
·
4 min read
Biotech Beach

Children’s Hospital Los Angeles Awarded $2 Million to Address Adverse Childhood Experiences

Children’s Hospital Los Angeles has been awarded a $2 million grant from the state of California to study a precision medicine approach to screening children for adverse childhood experiences.

June 3, 2021
·
6 min read
Foresight Diagnostics to Present Clinical Data of Industry-Leading Minimal Residual Disease (MRD) Technology in Lymphoma and Lung Cancer at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

Foresight Diagnostics announced today that two abstracts that report the clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) and non-small cell lung cancer (NSCLC) were chosen for presentation at the virtual 2021 American Society of Clinical Oncology (ASCO) Annual Meeting on June 4-8, 2021.

June 3, 2021
·
3 min read
Biotech Beach

Anivive Highlighted in Scientific American Article on Breakthrough Fungal Vaccine

Anivive’s initiative to develop a vaccine against canine Valley Fever is gaining attention as the threat of systemic fungal diseases escalates globally.

June 3, 2021
·
3 min read